Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Paracrine Signaling01:21

Paracrine Signaling

54.7K
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
54.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity-Related Circulating Endothelial Extracellular Vesicles Negatively Affect Cerebral Microvascular Cell Function.

American journal of physiology. Endocrinology and metabolism·2026
Same author

AGE-RELATED CIRCULATING ENDOTHELIAL EXTRACELLULAR VESICLES PROMOTE CEREBRAL MICROVASCULAR CELL DYSFUNCTION.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Effect of 17β-estradiol on brain microvascular endothelial cell oxidative stress, apoptotic susceptibility, and fibrinolytic capacity.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Early women's health research on endurance exercise training and cardiovascular aging at the University of Colorado Boulder using the masters athlete model.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Obesity-related elevation in circulating endothelial-derived extracellular microvesicles and endothelial fibrinolytic dysfunction.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Circulating endothelial extracellular vesicles progressively increase with age and are associated with endothelial vasodilator dysfunction.

American journal of physiology. Regulatory, integrative and comparative physiology·2025

Related Experiment Video

Updated: Jun 5, 2025

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

9.6K

Microvesicles Derived from Nitric Oxide Synthase-Inhibited Endothelial Cells Promote Cell Dysfunction.

Vinicius P Garcia1, Kelly A Stockelman1, Ma'ayan V Levy1

  • 1Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, USA.

Journal of Vascular Research
|December 10, 2024
PubMed
Summary

Endothelial nitric oxide synthase (eNOS) inhibition increases endothelial microvesicles (EMVs) release. These EMVs negatively impact endothelial cells, promoting inflammation and apoptosis.

Keywords:
ApoptosisEndothelial cellsEndothelial microvesiclesFibrinolysisInflammationNitric oxide

More Related Videos

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
00:06

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.0K
Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins
10:07

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Published on: March 17, 2023

1.9K

Related Experiment Videos

Last Updated: Jun 5, 2025

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

9.6K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
00:06

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.0K
Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins
10:07

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Published on: March 17, 2023

1.9K

Area of Science:

  • Endothelial biology
  • Molecular biology
  • Cellular signaling

Background:

  • Endothelial nitric oxide synthase (eNOS) plays a crucial role in vascular health.
  • Endothelial microvesicles (EMVs) are implicated in intercellular communication and disease pathogenesis.
  • Understanding the impact of eNOS dysfunction on EMV release and function is vital.

Purpose of the Study:

  • To investigate if eNOS inhibition stimulates EMV release.
  • To determine the effects of EMVs from eNOS-inhibited cells on endothelial cell function.
  • To assess the impact on endothelial eNOS activity, inflammation, apoptosis, and t-PA levels.

Main Methods:

  • Human umbilical vein endothelial cells (HUVECs) were treated with an eNOS inhibitor (L-NAME).
  • EMVs were isolated from treated and untreated HUVECs and characterized.
  • HUVECs were exposed to these isolated EMVs to assess cellular responses.

Main Results:

  • eNOS inhibition significantly increased EMV release compared to controls.
  • EMVs from inhibited cells reduced endothelial eNOS expression, p-eNOS, and NO production.
  • These EMVs elevated inflammatory markers (IL-6, IL-8), activated NF-κB, increased apoptosis (caspase-3), and decreased t-PA.

Conclusions:

  • eNOS inhibition triggers increased EMV release.
  • The released EMVs possess a detrimental phenotype, adversely affecting endothelial cells.
  • This suggests a novel mechanism linking eNOS dysfunction to endothelial damage and inflammation.